conjunctival haemorrhage

H7_CONJUHAEMOR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H11.3 Cause of death: ICD-10 — H11.3 2 out of 7 registries used, show all original rules.	2749
4. Check minimum number of events None	2749
5. Include endpoints None	2749
6. Filter based on genotype QC (FinnGen only)	2749

Control definitions (FinnGen only)

Control exclude: H7_CONJUNCTIVA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H11
Name in latin: Haemorrhagia conjunctivae

NAME	H7_CONJUHAEMOR
CONTROL_EXCLUDE	H7_CONJUNCTIVA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H113
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H113
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to conjunctival haemorrhage based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17760	9353	8327
Only index persons	16686	8922	7764
Unadjusted period prevalence (%)
Whole population	0.25	0.27	0.23
Only index persons	0.31	0.33	0.30
Median age at first event (years)
Whole population	63.98	65.11	62.79
Only index persons	64.10	65.11	62.94

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2749	1504	1245
Unadjusted period prevalence (%)	0.53	0.51	0.55
Median age at first event (years)	64.97	63.40	66.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2449: Matched controls
24491

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H11.3

ICD-10 Finland

Conjunctival haemorrhage

14892.1

323.0

2436

278

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.7

118.7

1276

6975

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

8.1

111.7

265

360

H04.10

ICD-10 Finland

Dry eye syndrome

3.6

71.0

358

1114

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.2

69.5

1014

5930

H20.1

ICD-10 Finland

Chronic iridocyclitis

13.9

54.0

S01GX01

ATC

cromoglicic acid; ophthalmic

2.7

50.6

378

1524

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.5

49.6

446

2000

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.4

49.5

500

2381

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

5.0

46.4

157

333

H02AB06

ATC

prednisolone; systemic

1.8

44.7

1204

8453

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.5

43.1

365

1575

H57.1

ICD-10 Finland

Ocular pain

5.1

41.8

137

280

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

39.4

755

4654

M79.6

ICD-10 Finland

Pain in limb

1.8

39.4

894

5845

R51.80

ICD-10 Finland

Headache

2.4

39.2

382

1768

F02

ICPC

Red eye

3.9

37.0

160

431

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

34.1

1134

8234

B01AA03

ATC

warfarin; systemic

1.9

33.7

589

3474

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

4.0

31.5

132

346

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

31.0

826

5573

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

3.6

29.7

139

401

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

29.4

823

5612

H15.1

ICD-10 Finland

Episcleritis

7.7

29.1

N02BE01

ATC

paracetamol; systemic, rectal

1.9

28.6

2080

18412

A02BC02

ATC

pantoprazole; systemic

1.6

27.9

1572

12861

S18

ICPC

Laceration/cut

1.6

27.7

1051

7759

J01DB01

ATC

cefalexin; oral

1.7

27.6

1928

16704

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

26.6

576

3612

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

26.6

1558

12788

R06.0

ICD-10 Finland

Dyspnoea

1.7

26.5

641

4163

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

26.2

614

3941

R06AE07

ATC

cetirizine; oral

1.6

26.2

922

6643

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

26.0

742

5050

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

5.4

25.7

147

R01AD12

ATC

fluticasone furoate; nasal

1.7

25.5

595

3811

M54.5

ICD-10 Finland

Low back pain

1.7

25.5

750

5139

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

25.4

425

2436

R42

ICD-10 Finland

Dizziness and giddiness

1.8

25.2

556

3500

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

9.6

25.0

A02BC05

ATC

esomeprazole; systemic

1.6

24.9

968

7131

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

24.8

449

2647

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

24.6

856

6127

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.3

24.4

254

1197

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

24.3

390

2198

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

23.9

714

4895

H16.0

ICD-10 Finland

Corneal ulcer

3.1

23.7

132

435

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

23.7

615

4052

F29

ICPC

Eye symptom/complaint other

2.4

23.5

216

959

AA1AD

NOMESCO Finland

CT of head and brain

1.7

23.4

613

4045

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

23.4

290

1479

R03AC02

ATC

salbutamol; inhalant

1.5

23.2

1172

9142

R03DC03

ATC

montelukast; oral

1.9

23.2

361

2012

UJF32

NOMESCO Finland

Coloscopy

1.6

22.8

664

4508

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.2

22.7

259

1274

E0000UV

ATC

1.6

22.6

874

6388

R01AD09

ATC

mometasone; nasal

1.6

22.4

938

6984

G47.3

ICD-10 Finland

Sleep apnoea

1.7

22.2

498

3135

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

22.2

1210

9567

N03AX16

ATC

pregabalin; oral

1.7

21.8

565

3706

J01FA06

ATC

roxithromycin; oral

1.5

21.8

925

6890

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

4.1

21.7

211

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.6

21.5

159

628

S01FA04

ATC

cyclopentolate; ophthalmic

6.5

21.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

21.2

624

4234

XCH00

NOMESCO Finland

Eye pressure measurement

2.9

21.2

133

476

N02AX02

ATC

tramadol; systemic, rectal

1.5

21.1

999

7621

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

21.0

473

2973

H02AB04

ATC

methylprednisolone; systemic

1.9

20.9

350

1997

S01GX08

ATC

ketotifen; ophthalmic

4.7

20.8

158

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

20.6

429

2632

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

20.6

129

461

R01AD08

ATC

fluticasone; nasal

1.6

20.5

583

3917

S01ED51

ATC

timolol, combinations; ophthalmic

2.2

20.5

218

1038

SPAT1153

SPAT

Removal of sutures

1.6

20.3

787

5711

SPAT1263

SPAT

Sampling

1.5

20.3

993

7605

SPAT1312

SPAT

General health counselling

1.6

20.3

737

5272

WX110

NOMESCO Finland

Local anesthesy

1.5

20.0

1523

12824

XCK00

NOMESCO Finland

Perimetry

2.3

19.8

194

887

J01CA04

ATC

amoxicillin; systemic

1.5

19.7

1820

15960

XF404

NOMESCO Finland

Ambulatory ECG

2.0

19.6

262

1373

H10.4

ICD-10 Finland

Chronic conjunctivitis

29.2

19.6

M45

ICD-10 Finland

Ankylosing spondylitis

4.4

19.6

164

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

19.5

443

2786

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

19.5

836

6198

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

19.5

908

6861

Z00.0

ICD-10 Finland

General medical examination

1.7

19.5

444

2794

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

5.6

19.5

104

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

19.4

1356

11173

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

19.3

1040

8105

J01DA01

ATC

[U] cefalexin; systemic

1.5

19.2

1403

11655

C07AB07

ATC

bisoprolol; oral

1.5

19.2

1152

9187

R05

ICD-10 Finland

Cough

1.7

19.1

460

2942

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

19.0

412

2555

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.1

19.0

232

1170

L03

ICPC

Low back symptom/complaint

1.6

18.9

543

3646

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

18.8

646

4537

J01AA02

ATC

doxycycline; systemic

1.5

18.8

1813

15941

R06AX27

ATC

desloratadine; oral

1.6

18.7

508

3361

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.8

18.6

126

473

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

18.5

164

713

R07.3

ICD-10 Finland

Other chest pain

2.0

18.5

241

1249

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

18.4

1027

8039

L17

ICPC

Foot/toe symptom/complaint

1.6

18.3

590

4076

L04AX01

ATC

azathioprine; systemic

2.8

18.3

121

448

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

18.3

799

5931

L04AA06

ATC

mycophenolic acid; systemic

4.9

18.2

126

J01FA09

ATC

clarithromycin; systemic

1.5

18.2

676

4837

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

18.2

401

2497

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

18.1

1199

9710

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

18.1

1133

9068

J01FA10

ATC

azithromycin; systemic

1.5

18.1

1213

9848

K78

ICPC

Atrial fibrillation/flutter

2.1

18.1

224

1140

ZXA00

NOMESCO Finland

Right side

1.5

17.7

659

4711

114

Kela drug reimbursment

Glaucoma

2.0

17.5

242

1282

R04.0

ICD-10 Finland

Epistaxis

2.2

17.3

191

923

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

17.2

365

2245

R05

ICPC

Cough

1.6

17.0

503

3391

R74

ICPC

Upper respiratory infection acute

1.6

16.9

522

3560

UKC02

NOMESCO Finland

Cystoscopy

1.7

16.8

399

2537

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

16.7

892

6881

A01

ICPC

Pain general/multiple sites

2.1

16.6

192

948

H11.1

ICD-10 Finland

Conjunctival degenerations and deposits

171.1

16.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

16.5

176

837

H26.3

ICD-10 Finland

Drug-induced cataract

10.8

16.4

H40.0

ICD-10 Finland

Glaucoma suspect

2.1

16.4

199

1003

H26.4

ICD-10 Finland

After-cataract

1.9

16.4

252

1391

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

16.3

482

3246

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

16.3

579

4078

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

16.2

226

1201

127

Kela drug reimbursment

Transplant complication

5.0

16.1

103

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

16.1

266

1505

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

16.0

784

5925

207

Kela drug reimbursment

Chronic arrhythmias

1.7

15.9

384

2448

R50.9

ICD-10 Finland

Fever, unspecified

1.8

15.8

319

1925

C03CA01

ATC

furosemide; systemic

1.5

15.8

710

5264

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

15.8

545

3809

S05.9

ICD-10 Finland

Injury of eye and orbit, unspecified

7.1

15.8

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

4.7

15.8

114

G44.2

ICD-10 Finland

Tension-type headache

1.8

15.8

276

1591

M03BX02

ATC

tizanidine; oral

1.4

15.7

1324

11101

H01.0

ICD-10 Finland

Blepharitis

2.6

15.7

117

467

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

15.5

353

2209

R03BA05

ATC

fluticasone; inhalant

1.7

15.5

382

2447

N03AX12

ATC

gabapentin; oral

1.7

15.4

357

2247

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

15.3

286

1684

CKC12

NOMESCO Finland

Photocoagulation of retina

2.6

15.3

117

471

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

15.2

146

662

K02.1

ICD-10 Finland

Caries of dentine

1.4

15.2

1164

9563

A02BC03

ATC

lansoprazole; oral

1.5

15.2

667

4914

J01FF01

ATC

clindamycin; systemic

1.5

15.1

600

4326

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

15.1

942

7451

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

15.0

412

2715

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

15.0

252

1433

J01MA12

ATC

levofloxacin; systemic

1.6

15.0

429

2859

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

15.0

194

1001

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

14.9

269

1565

J05AB01

ATC

aciclovir; systemic

1.6

14.9

444

2987

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

14.9

369

2365

S01ED01

ATC

timolol; ophthalmic

2.6

14.9

112

449

M79.1

ICD-10 Finland

Myalgia

1.8

14.9

275

1614

H02AB07

ATC

prednisone; oral

1.7

14.6

329

2052

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

14.6

243

1376

A02BA02

ATC

ranitidine; systemic

1.6

14.5

458

3123

-1

NOMESCO Finland

1.5

14.5

678

5053

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

5.3

14.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

14.5

1401

11962

SPAT1260

SPAT

Consultation of another employee

1.6

14.4

424

2845

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

14.4

390

2559

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.2

425

2857

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

14.1

158

771

SPAT1310

SPAT

Counselling related to known health issue

1.4

14.0

723

5489

F01

ICPC

Eye pain

3.3

14.0

216

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

13.9

225

1262

M25.5

ICD-10 Finland

Pain in joint

1.5

13.9

595

4346

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

13.9

156

760

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

13.8

273

1638

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

13.7

275

1654

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

13.7

168

850

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

13.6

217

1211

H26.2

ICD-10 Finland

Complicated cataract

4.5

13.6

105

B01AB05

ATC

enoxaparin; parenteral

1.4

13.6

712

5415

XQ800

NOMESCO Finland

Prick test

2.2

13.6

142

669

ZXA05

NOMESCO Finland

Left side

1.5

13.5

602

4431

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

13.5

673

5066

L15

ICPC

Knee symptom/complaint

1.5

13.5

465

3236

S01EE01

ATC

latanoprost; ophthalmic

2.1

13.5

164

827

R00.2

ICD-10 Finland

Palpitations

2.1

13.5

153

750

S01GX05

ATC

lodoxamide; ophthalmic

7.5

13.4

S01GX02

ATC

levocabastine; ophthalmic

2.7

13.4

357

M48.0

ICD-10 Finland

Spinal stenosis

1.7

13.4

292

1803

XF402

NOMESCO Finland

ECG with work load test

1.7

13.4

284

1741

L01

ICPC

Neck symptom/complaint

1.7

13.3

288

1771

J01MA02

ATC

ciprofloxacin; systemic

1.4

13.3

875

6941

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

13.3

975

7887

WZA90

NOMESCO Finland

Other doctors statement

1.5

13.3

485

3420

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.3

1067

8767

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.5

13.2

105

435

L04AD01

ATC

ciclosporin; systemic

3.7

13.2

157

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

13.2

338

2182

Z01.2

ICD-10 Finland

Dental examination

1.4

13.2

821

6446

R53

ICD-10 Finland

Malaise and fatigue

1.5

13.0

443

3068

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

13.0

294

1833

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

12.9

158

800

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

12.9

158

801

M01AH05

ATC

etoricoxib; oral

1.4

12.9

1246

10542

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

12.9

184

988

R51.81

ICD-10 Finland

Facial pain NOS

3.6

12.8

161

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

12.8

215

1222

C01BC04

ATC

flecainide; systemic

2.5

12.8

102

424

AN1

Coronary angiography

1.7

12.7

306

1939

D07AC01

ATC

betamethasone; topical

1.4

12.7

731

5649

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

12.6

366

2438

Z71.8

ICD-10 Finland

Other specified counselling

1.5

12.6

485

3458

Z00.8

ICD-10 Finland

Other general examinations

2.0

12.6

157

800

R03BA01

ATC

beclometasone; inhalant

1.7

12.5

287

1796

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

12.5

146

724

L12

ICPC

Hand/finger symptom/complaint

1.7

12.5

299

1896

KMAK

NOMESCO Finland

1.4

12.4

1046

8631

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

12.2

685

5259

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

12.2

203

1152

S01BC03

ATC

diclofenac; ophthalmic

3.0

12.1

224

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

12.1

365

2457

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

12.0

187

1034

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

12.0

545

4012

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

12.0

147

744

R60.0

ICD-10 Finland

Localized oedema

1.7

12.0

261

1607

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

12.0

121

563

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

12.0

159

830

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

12.0

194

1090

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

12.0

535

3927

R52.9

ICD-10 Finland

Pain, unspecified

1.8

11.9

192

1077

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

11.9

319

2082

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

11.8

238

1436

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

10.6

11.7

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

11.7

832

6653

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

19.0

11.6

SPAT1325

SPAT

Vaccination

1.4

11.6

801

6372

A02BC01

ATC

omeprazole; systemic

1.4

11.5

599

4523

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

11.5

858

6908

SFA00

NOMESCO Finland

Small filling

1.7

11.5

268

1685

H01

ICPC

Ear pain/earache

1.8

11.5

201

1159

Z3231

NOMESCO Finland

Registered nurse

1.4

11.5

601

4543

P01AB01

ATC

metronidazole; oral, rectal

1.4

11.5

830

6646

ZXE00

NOMESCO Finland

One hour or less

1.4

11.5

846

6797

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

11.5

562

4197

R03AC03

ATC

terbutaline; inhalant

1.6

11.5

289

1856

H15.0

ICD-10 Finland

Scleritis

13.7

11.4

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.0

11.4

153

805

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.1

11.4

124

597

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

11.3

222

1329

C01CA24

ATC

epinephrine; parenteral

2.2

11.3

109

499

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

4.6

11.3

A98

ICPC

Health maint/preventive medicine

1.7

11.2

2257

21456

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.5

11.2

344

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

11.1

373

2569

D82

ICPC

Teeth/gum disease

1.4

11.1

657

5078

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

11.1

318

2110

S29

ICPC

Skin symptom/complaint other

1.5

11.1

358

2443

E000001

ATC

1.5

11.1

404

2837

N06AX21

ATC

duloxetine; oral

1.7

11.0

214

1273

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

11.0

298

1948

S01FA02

ATC

scopolamine; ophthalmic

4.8

11.0

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.9

11.0

222

S16

ICPC

Bruise/contusion

2.5

10.9

325

SPAT1229

SPAT

Assessment of need for aid

1.8

10.9

201

1179

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

10.9

463

3357

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.8

509

3766

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.9

10.8

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

10.8

191

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

10.7

127

636

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

10.7

401

2830

S01BC05

ATC

ketorolac; ophthalmic

2.3

10.7

439

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

10.6

217

1314

WX002

NOMESCO Finland

Sedation and analgesia

1.5

10.6

436

3136

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

10.6

179

1022

S01EC04

ATC

brinzolamide; ophthalmic

2.3

10.6

414

J02AC01

ATC

fluconazole; systemic

1.4

10.6

759

6052

R21

ICPC

Throat symptom/complaint

1.5

10.6

330

2236

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.6

302

2001

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

10.5

621

4785

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

10.5

830

6723

R03BA02

ATC

budesonide; inhalant

1.5

10.5

350

2407

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

10.4

181

1042

R11

ICD-10 Finland

Nausea and vomiting

1.8

10.4

177

1013

C07AA05

ATC

propranolol; systemic

1.5

10.4

374

2619

L57.0

ICD-10 Finland

Actinic keratosis

1.7

10.4

242

1521

S06.0

ICD-10 Finland

Concussion

1.7

10.4

221

1353

K30

ICD-10 Finland

Functional dyspepsia

1.7

10.3

216

1316

SPAT1301

SPAT

No procedures

1.4

10.3

712

5635

K99

ICPC

Cardiovascular disease other

2.6

10.3

302

N06AB04

ATC

citalopram; systemic

1.5

10.3

452

3294

C08CA01

ATC

amlodipine; oral

1.4

10.3

820

6644

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

10.3

508

3790

S01GX09

ATC

olopatadine; ophthalmic

4.3

10.3

R03BA08

ATC

ciclesonide; inhalant

1.8

10.2

172

979

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

10.2

442

3214

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

10.2

394

2798

K07.60

ICD-10 Finland

Snapping jaw

2.4

10.2

370

C09CA01

ATC

losartan; oral

1.4

10.2

547

4148

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

10.1

150

818

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

10.0

140

747

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

9.9

147

803

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

9.8

138

737

H30.2

ICD-10 Finland

Posterior cyclitis

20.1

9.8

H11.4

ICD-10 Finland

Other conjunctival vascular disorders and cysts

20.1

9.8

A46

ICD-10 Finland

Erysipelas

1.5

9.8

325

2229

J01MA14

ATC

moxifloxacin; systemic

1.7

9.7

197

1187

M02AA07

ATC

piroxicam; topical

1.3

9.7

812

6617

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

9.6

150

831

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

9.6

262

1716

H25.8

ICD-10 Finland

Other senile cataract

1.6

9.5

263

1726

SPAT1254

SPAT

Administration of medicine

1.5

9.5

328

2272

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

6.0

9.5

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

3.7

9.5

110

H36.01

ICD-10 Finland

Diabetic maculopathy

3.8

9.5

105

C10AA07

ATC

rosuvastatin; oral

1.4

9.5

530

4038

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

9.5

277

1845

R02

ICPC

Shortness of breath/dyspnoea

1.6

9.5

265

1745

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

9.4

303

2064

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

9.4

380

2718

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

9.4

163

940

R96

ICPC

Asthma

1.7

9.3

180

1073

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

9.3

149

834

R31

ICD-10 Finland

Unspecified haematuria

1.6

9.3

228

1452

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

9.3

269

1788

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

9.3

217

1366

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

9.3

102

496

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

9.2

319

2208

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.1

9.2

100

486

L08

ICPC

Shoulder symptom/complaint

1.5

9.2

393

2846

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.0

9.1

117

606

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

9.1

181

1087

ZXA10

NOMESCO Finland

Bilateral

1.4

9.1

410

3002

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

9.1

226

1447

F75

ICPC

Contusion/haemorrhage eye

8.3

9.1

P01BA02

ATC

hydroxychloroquine; oral

1.7

9.0

172

1020

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

9.0

145

814

TK800

NOMESCO Finland

Hemodialysis

2.8

9.0

199

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

9.0

190

1162

M01AE02

ATC

naproxen; oral, rectal

1.3

9.0

1152

9949

ZXD05

NOMESCO Finland

Urgent procedure

1.4

8.9

637

5050

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.9

215

1361

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.4

8.9

324

R06AX26

ATC

fexofenadine; oral

2.0

8.9

106

531

A07AA02

ATC

nystatin; oral

1.8

8.9

144

810

C08DA01

ATC

verapamil; systemic

2.1

8.9

471

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

8.9

706

5694

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.8

517

3965

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.8

322

2255

UDC00

NOMESCO Finland

Ear microscopy

1.7

8.8

163

959

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

8.8

180

1093

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

8.7

431

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.6

8.7

249

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

8.7

365

R07.0

ICD-10 Finland

Pain in throat

1.9

8.7

117

616

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

8.7

347

SPAT1262

SPAT

Handing over of treatment supplies

1.4

8.7

402

2955

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

8.6

127

693

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

8.6

147

841

C01AA05

ATC

digoxin; systemic

1.7

8.6

185

1139

L28

ICPC

Limited function/disability (L)

1.5

8.6

352

2527

K80

ICPC

Cardiac arrhythmia NOS

1.7

8.6

161

953

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

8.5

126

688

S97

ICPC

Chronic ulcer skin

1.9

8.5

126

689

A11

ICPC

Chest pain NOS

1.7

8.5

162

960

R51

ICD-10 Finland

Headache

2.0

8.5

494

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

8.5

190

1179

I20.09

ICD-10 Finland

Unstable angina

1.8

8.5

135

757

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

8.5

213

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

8.5

A01AB09

ATC

miconazole; local oral

1.6

8.4

193

1207

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

8.4

171

1033

M15

ICD-10 Finland

Polyarthrosis

1.9

8.4

113

599

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

8.4

200

1266

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

8.4

157

926

H3601, H113

ICD-10 Finland

+∞

8.3

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.1

8.3

430

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

8.3

150

878

R05FB02

ATC

cough suppressants and expectorants

1.3

8.3

809

6708

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

8.3

251

1688

L04AA01

ATC

[U] ciclosporin; systemic

3.3

8.3

124

N01

ICPC

Headache

1.7

8.3

163

977

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

8.2

556

4358

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

8.2

199

1265

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.6

8.2

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.8

8.2

D07AA02

ATC

hydrocortisone; topical

1.6

8.2

241

1608

-44

ICPC

Preventive immunization/medic

1.6

8.2

192

1211

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

8.2

340

2444

M54.2

ICD-10 Finland

Cervicalgia

1.8

8.1

141

811

WX290

NOMESCO Finland

Other blockade of nerve

1.3

8.1

785

6493

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

8.1

167

1014

B01AF02

ATC

apixaban; oral

1.6

8.1

233

1547

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

8.1

128

715

C10AX09

ATC

ezetimibe; oral

1.6

8.1

237

1579

R75

ICPC

Sinusitis acute/chronic

2.1

8.1

398

J46

ICD-10 Finland

Status asthmaticus

2.4

8.1

262

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

8.1

933

7908

R06AE09

ATC

levocetirizine; oral

1.5

8.1

241

1613

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

8.0

466

3564

B01AE07

ATC

dabigatran etexilate; oral

2.0

8.0

492

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.0

351

2551

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.5

8.0

246

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

7.9

277

1919

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.2

7.9

337

XKD00

NOMESCO Finland

Uroflowmetry

1.4

7.9

353

2570

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

7.9

160

966

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.5

7.9

232

D07AC13

ATC

mometasone; topical

1.3

7.9

578

4586

WZC30

NOMESCO Finland

Teaching

1.5

7.9

279

1943

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.8

622

4996

X58

ICD-10 Finland

Exposure to other specified factors

1.5

7.8

256

1752

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.9

7.8

156

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

7.8

197

1266

ZXC50

NOMESCO Finland

Cryotherapy

2.2

7.7

327

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.9

7.7

117

644

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.3

7.7

K04

ICPC

Palpitations/awareness of heart

1.9

7.7

107

572

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

7.7

684

5588

J45

ICD-10 Finland

Asthma

1.6

7.7

182

1152

XQ802

NOMESCO Finland

Epicutan test

2.2

7.6

343

B07.9

ICD-10 Finland

Verruca simplex

2.3

7.6

301

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

7.6

128

733

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

7.6

493

3838

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

7.6

452

3468

D06BX01

ATC

metronidazole; topical

1.6

7.6

192

1235

D19

ICPC

Teeth/gum symptom/complaint

1.4

7.6

474

3668

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

2.8

7.6

161

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.0

7.6

442

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

7.5

187

1195

H02.3

ICD-10 Finland

Blepharochalasis

1.7

7.5

138

812

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

7.5

177

H29

ICPC

Ear symptom/complaint other

1.6

7.5

213

1409

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.5

7.5

228

R06.2

ICD-10 Finland

Wheezing

2.0

7.5

447

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

7.5

248

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

7.5

820

6883

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

7.5

149

899

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.1

7.4

375

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.8

7.4

H13

ICPC

Plugged feeling ear

1.4

7.4

388

2910

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.1

7.4

366

M01AX17

ATC

nimesulide; oral

1.3

7.4

530

4184

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

7.4

205

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

7.4

101

539

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.8

7.4

120

679

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

7.4

431

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.5

7.4

213

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

7.3

512

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

2.3

7.3

271

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

7.3

148

897

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

7.3

134

788

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.2

7.3

304

SPAT1131

SPAT

Colonoscopy

2.1

7.3

350

S01KA02

ATC

hypromellose; ophthalmic

2.9

7.3

146

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.6

7.3

190

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.8

7.3

160

S01EA03

ATC

apraclonidine; ophthalmic

3.6

7.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

7.2

160

991

JJC00

NOMESCO Finland

Allogenic transplantation of liver

15.8

7.2

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

7.2

119

679

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

7.2

463

3600

S01GX06

ATC

emedastine; ophthalmic

4.8

7.1

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

7.1

325

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

7.1

624

5076

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

7.1

132

779

H3601, E113

ICD-10 Finland

3.0

7.1

128

M01AH02

ATC

rofecoxib; oral

1.5

7.1

287

2051

N17

ICPC

Vertigo/dizziness

1.5

7.1

234

1602

H05AA02

ATC

teriparatide; parenteral

6.0

7.1

J20

ICD-10 Finland

Acute bronchitis

1.6

7.0

188

1227

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.0

495

3899

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

7.0

526

E000006

ATC

1.7

7.0

145

884

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

7.0

168

S01AD03

ATC

aciclovir; ophthalmic

2.1

7.0

331

C05AA08

ATC

fluocortolone; rectal, topical

1.4

7.0

294

2116

A03FA02

ATC

cisapride; oral, rectal

1.6

7.0

164

1034

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

7.0

N06AX11

ATC

mirtazapine; oral

1.3

7.0

626

5107

D01

ICPC

Abdominal pain/cramps general

1.6

7.0

190

1244

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.5

6.9

Z3226

NOMESCO Finland

Physiotherapist

1.4

6.9

381

2881

W19

ICD-10 Finland

Unspecified fall

1.6

6.9

193

1271

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

6.9

118

678

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.2

6.9

B01AC04

ATC

clopidogrel; oral

1.4

6.9

346

2574

H92.0

ICD-10 Finland

Otalgia

1.9

6.9

506

R01AD05

ATC

budesonide; nasal

1.7

6.9

134

803

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.4

6.9

240

C10AA05

ATC

atorvastatin; oral

1.3

6.9

857

7291

J45.8

ICD-10 Finland

Mixed asthma

2.3

6.9

272

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

13.8

6.9

R01AD11

ATC

triamcinolone; nasal

1.6

6.9

166

1055

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.9

502

3976

L02

ICPC

Back symptom/complaint

1.6

6.9

163

1034

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

6.8

561

4518

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

6.8

416

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

6.8

117

672

VALMI

NOMESCO Finland

1.4

6.8

439

3406

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.9

6.8

100

547

M01AC06

ATC

meloxicam; systemic, rectal

1.3

6.8

760

6378

H02AB09

ATC

hydrocortisone; systemic

2.5

6.8

198

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

6.8

476

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

6.8

535

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

6.7

335

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.7

495

3918

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

6.7

433

3361

A12AA04

ATC

calcium carbonate; oral

2.9

6.7

137

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

6.7

120

701

C09CA06

ATC

candesartan; oral

1.4

6.7

424

3279

C02AC05

ATC

moxonidine; oral

1.8

6.7

100

552

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.5

6.7

251

1768

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

6.7

293

2126

EBA00

NOMESCO Finland

Extraction of tooth

1.3

6.7

642

5278

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

6.7

325

SPAT1211

SPAT

Application of soft bandage

1.5

6.7

193

1285

XCW10

NOMESCO Finland

Assessment of vision

4.4

6.6

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.0

6.6

378

R03AC13

ATC

formoterol; inhalant

1.8

6.6

546

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

6.6

156

987

C01DA14

ATC

isosorbide mononitrate; oral

1.4

6.6

342

2559

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

6.6

112

644

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.6

452

3542

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

6.6

763

6424

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

6.6

475

C07AB02

ATC

metoprolol; systemic

1.3

6.6

460

3616

H3603, E103

ICD-10 Finland

4.0

6.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

6.6

132

797

SPAT1285

SPAT

Provision of consultation response

1.8

6.6

113

652

S20.2

ICD-10 Finland

Contusion of thorax

1.8

6.6

102

570

A97

ICPC

No disease

1.4

6.6

295

2150

L13

ICPC

Hip symptom/complaint

1.4

6.6

333

2483

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

6.5

145

902

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.3

6.5

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.3

6.5

235

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

6.9

6.5

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.7

6.5

148

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

6.5

116

677

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.6

6.5

179

1178

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

6.5

201

1358

S01EC01

ATC

acetazolamide; systemic

2.3

6.5

240

R03BC03

ATC

nedocromil; inhalant

1.7

6.5

136

834

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.2

6.4

282

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

6.4

329

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

6.4

334

2502

B01AF01

ATC

rivaroxaban; oral

1.4

6.4

258

1842

L29

ICPC

Musculoskeletal sympt/complt other

1.6

6.4

147

924

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.1

6.4

331

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

6.4

104

M35.7

ICD-10 Finland

Hypermobility syndrome

3.9

6.4

S15

ICPC

Foreign body in skin

1.7

6.4

122

730

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

6.4

102

575

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

6.4

191

1282

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

6.4

452

SPAT1058

SPAT

PEF monitoring instruction

1.6

6.3

170

1112

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

6.3

531

4284

Z94.4

ICD-10 Finland

Liver transplant status

8.2

6.3

A11CC03

ATC

alfacalcidol; systemic

2.3

6.3

245

318

Kela drug reimbursment

Teriparatide

5.2

6.3

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

5.2

6.3

K08.80

ICD-10 Finland

Toothache NOS

1.7

6.3

130

795

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.8

6.3

139

XF640

NOMESCO Finland

2.1

6.3

338

S01FA01

ATC

atropine; ophthalmic

6.0

6.3

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

3.5

6.3

S01EE05

ATC

tafluprost; ophthalmic

2.0

6.3

389

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.1

6.3

326

J05AB11

ATC

valaciclovir; oral

1.4

6.3

247

1758

D06

ICPC

Abdominal pain localized other

1.6

6.3

149

945

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

6.3

121

725

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

6.2

110

640

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

6.2

231

1623

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.1

6.2

306

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.3

6.2

220

R04.2

ICD-10 Finland

Haemoptysis

2.0

6.2

381

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.2

355

2704

I49.5

ICD-10 Finland

Sick sinus syndrome

1.9

6.2

499

SPAT1053

SPAT

Memory test

1.4

6.2

338

2555

C03DA01

ATC

spironolactone; oral

1.5

6.2

226

1582

M01AB55

ATC

diclofenac, combinations; oral

1.6

6.2

148

942

L84

ICD-10 Finland

Corns and callosities

2.0

6.2

371

C08CA13

ATC

lercanidipine; oral

1.4

6.2

282

2066

H10

ICD-10 Finland

Conjunctivitis

1.8

6.2

546

S04

ICPC

Lump/swelling localized

1.6

6.2

171

1128

K02.0

ICD-10 Finland

Caries limited to enamel

1.5

6.1

209

1444

WX140

NOMESCO Finland

Parabulbar anesthesy

1.8

6.1

532

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.7

6.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

6.1

210

1450

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.2

6.1

R01AD01

ATC

beclometasone; nasal

1.4

6.1

260

1879

J01FA15

ATC

telithromycin; oral

1.5

6.1

184

1237

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

6.1

207

1427

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

6.1

430

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.8

6.1

519

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

6.1

123

748

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

6.1

153

983

R52.2

ICD-10 Finland

Other chronic pain

2.1

6.1

303

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

6.1

150

962

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.4

6.1

205

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

6.1

124

755

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.5

6.1

179

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

6.1

121

734

M01AX05

ATC

glucosamine; oral

1.3

6.0

450

3568

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.5

6.0

171

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

6.0

174

1157

A03

ICPC

Fever

1.4

6.0

253

1821

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013115) Eosinophils [#/volume] in Blood

1600

11772

1.86

53.20

7.8

6.0

e9/l

0.2

1.08

1435

10235

(3006315) Basophils [#/volume] in Blood

1558

11383

1.85

52.82

7.5

5.7

e9/l

0.0

0.54

1384

9771

(3001604) Monocytes [#/volume] in Blood

1547

11330

1.84

51.49

7.4

5.7

e9/l

0.6

0.69

1375

9709

(3019198) Lymphocytes [#/volume] in Blood

1567

11610

1.81

49.28

7.5

5.8

e9/l

2.0

1.9

0.12

1409

10145

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1098

7338

1.83

48.48

2.5

2.2

u/l

161.1

235.1

2.94

1039

6869

(3013707) Erythrocyte sedimentation rate by Westergren method

2087

17000

1.95

47.33

6.1

4.1

mm/h

12.3

13.2

2.16

1935

15653

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1305

9273

1.78

46.17

5.2

3.8

ng/l

90.5

105.3

0.08

1002

6762

(3022217) INR in Platelet poor plasma by Coagulation assay

590

3328

1.98

43.18

37.3

26.6

inr

1.5

1.4

1.29

456

(3019069) Monocytes/100 leukocytes in Blood

1439

10700

1.72

41.81

8.0

6.4

8.6

8.8

1.21

1349

9985

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1285

9272

1.72

41.57

3.7

2.8

ug/l

135.8

142.1

0.41

1191

8479

(3006504) Eosinophils/100 leukocytes in Blood

1432

10651

1.72

41.41

7.6

6.0

2.7

2.8

0.92

1337

9903

(3013650) Neutrophils [#/volume] in Blood by Automated count

1703

13312

1.73

40.82

10.1

9.0

e9/l

4.1

4.2

0.33

1526

11582

(3032080) INR in Blood by Coagulation assay

1356

9987

1.71

40.22

16.0

10.1

inr

1.4

1.3

1.33

427

2800

(3002030) Lymphocytes/100 leukocytes in Blood

1448

10938

1.68

38.36

7.9

6.2

26.9

27.2

0.39

1352

10152

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2142

18044

1.85

37.97

10.2

7.6

u/l

78.0

80.0

0.97

2030

16973

(3018010) Neutrophils/100 leukocytes in Blood

1428

10768

1.68

37.90

7.5

6.0

58.1

57.7

0.52

1334

10032

(3013826) Glucose [Moles/volume] in Serum or Plasma

1748

13911

1.70

37.74

6.8

4.7

mmol/l

6.8

0.26

1669

13081

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1053

7350

1.70

37.27

3.0

2.6

u/l

58.9

58.2

0.12

975

6776

(3022096) Basophils/100 leukocytes in Blood

1379

10372

1.66

36.40

7.7

6.1

0.7

0.19

1286

9649

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1554

12098

1.65

35.44

9.4

6.9

mmol/l

1.2

0.49

1299

10193

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2514

22531

2.35

35.41

22.6

15.4

mg/l

21.8

25.0

5.48

2151

18038

(3037467) Urinalysis macro (dipstick) panel - Urine

1917

15819

1.70

34.33

6.0

4.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

750

4871

1.74

33.85

2.2

1.8

mg/l

1.2

1.3

0.40

562

3805

(42870588) Differential panel, method unspecified - Blood

1094

7877

1.65

33.36

7.3

5.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1853

15256

1.66

32.41

6.3

4.7

e6/l

849.7

2224.6

1.01

238

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

883

6087

1.66

31.51

2.7

2.3

mg/l

3.2

3.0

1.22

781

5167

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1035

7450

1.62

30.97

4.1

3.1

ng/l

1462.2

1577.9

0.43

903

6424

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2338

20665

1.88

30.13

5.9

4.8

mu/l

2.0

2.1

0.65

2123

18702

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1261

9575

1.59

29.82

2.7

2.2

nmol/l

80.0

78.5

1.07

1114

8475

(3019550) Sodium [Moles/volume] in Serum or Plasma

2574

23589

2.43

29.50

25.5

18.1

mmol/l

139.8

139.7

0.93

2532

22984

(3023103) Potassium [Moles/volume] in Serum or Plasma

2578

23647

2.45

29.39

25.7

18.2

mmol/l

4.0

0.87

2533

23007

(3037522) Nuclear Ab [Titer] in Serum

474

2803

1.84

28.88

1.5

1.3

titre

539.6

535.2

0.02

108

606

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

579

3648

1.74

28.41

1.4

1.3

iu/ml

35.6

38.0

0.15

190

1171

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2008

17138

1.64

27.81

4.8

4.0

pmol/l

15.0

14.9

0.44

1810

15415

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1541

12390

1.55

27.41

7.5

6.3

umol/l

11.8

11.6

0.28

1475

11759

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1397

11010

1.55

27.05

8.3

6.1

mmol/l

1.2

0.20

1245

9941

(3023368) Bacteria identified in Blood by Culture

940

6824

1.57

26.00

4.8

4.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

697

4744

1.63

25.12

1.9

1.8

nmol/l

1274.7

1180.1

1.69

524

3553

(3002582) Erythrocytes [#/volume] in Urine

976

7189

1.55

25.10

4.2

3.3

e6/l

69.9

82.6

0.15

821

5587

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2586

23985

2.32

24.67

25.3

18.2

umol/l

83.4

79.3

5.04

2586

23976

(3026493) Urate [Moles/volume] in Serum or Plasma

856

6145

1.57

24.55

3.5

2.7

umol/l

3486.3

5825.7

1.05

719

5273

(3018095) Leukocytes [#/volume] in Urine

1094

8294

1.53

24.51

4.7

3.8

e6/l

48.8

113.5

4.63

870

5984

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2434

22147

1.86

23.70

5.4

4.8

mmol/l

6.0

0.01

2190

20005

(3000850) Epithelial cells [#/volume] in Urine

726

5051

1.59

23.67

3.2

2.6

e6/l

3.9

5.5

5.03

653

4444

(3018677) aPTT in Platelet poor plasma by Coagulation assay

574

3770

1.66

23.64

2.4

2.1

30.4

29.9

0.86

555

3655

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2581

23984

2.25

23.41

14.9

10.9

u/l

25.5

0.02

2498

23064

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

609

4079

1.63

23.15

2.0

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

692

4786

1.60

23.04

6.1

4.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

197

922

2.22

23.00

2.1

1.8

u/l

37.9

39.1

0.39

177

801

(40768797) Stomach Pathology biopsy report

500

3202

1.69

22.58

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1511

12399

1.49

22.26

2.9

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2352

21292

1.72

21.89

19.7

14.5

ml/min/173m2

75.3

77.2

3.96

2021

17585

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

653

4540

1.57

20.97

1.3

1.2

u/ml

2.0

1.4

0.39

187

1189

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1252

9989

1.47

20.69

2.4

2.0

pmol/l

97.5

94.1

1.45

632

5126

(3007461) Platelets [#/volume] in Blood

2634

24828

2.46

20.62

32.5

22.7

e9/l

239.6

247.8

8.68

2589

24146

(3024731) MCV [Entitic volume]

2634

24835

2.45

20.48

32.4

22.7

91.5

91.4

0.60

2603

24433

(3035941) MCH [Entitic mass]

2634

24837

2.45

20.44

32.4

22.6

30.4

0.03

2603

24432

(3026361) Erythrocytes [#/volume] in Blood

2634

24838

2.45

20.42

32.6

22.7

e12/l

4.4

3.65

2587

24066

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

447

2851

1.68

20.32

1.9

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

2634

24845

2.44

20.28

32.7

22.9

g/l

133.1

134.3

3.94

2601

24444

(3010813) Leukocytes [#/volume] in Blood

2634

24845

2.44

20.28

32.6

22.8

e9/l

6.7

6.8

0.40

2586

24072

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2426

22251

1.77

20.28

5.4

4.6

mmol/l

4.6

1.41

2229

20411

(40761511) CBC panel - Blood by Automated count

2510

23268

1.91

20.12

21.5

14.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2409

22061

1.74

20.12

5.4

4.5

mmol/l

1.5

0.01

2197

20082

(3022948) Iron [Moles/volume] in Serum or Plasma

561

3799

1.60

20.04

3.4

2.5

umol/l

12.9

12.7

0.39

530

3515

(3030467) Casts [#/volume] in Urine by Automated count

881

6589

1.50

20.02

4.0

3.2

e6/l

0.4

0.5

0.76

719

5047

(3007164) IgA [Mass/volume] in Serum or Plasma

585

4002

1.59

20.02

1.5

g/l

2.4

2.5

1.43

342

2380

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

522

3476

1.62

19.99

1.3

1.2

u/ml

13.3

14.0

0.08

194

1306

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2328

21147

1.66

19.79

7.2

6.1

mmol/mol

40.5

40.3

0.50

2150

19421

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2464

22732

1.81

19.78

6.0

5.1

mmol/l

2.6

2.7

1.90

2249

20719

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2342

21308

1.67

19.77

4.8

4.1

mmol/l

1.3

0.25

2114

19247

(3036481) Cortisol [Moles/volume] in Serum or Plasma

343

2054

1.77

19.55

2.5

2.1

nmol/l

347.2

371.1

1.56

314

1872

(3048689) Calprotectin [Mass/mass] in Stool

391

2431

1.71

19.49

2.3

2.2

ug/g

144.2

145.6

0.02

304

1902

(3003458) Phosphate [Moles/volume] in Serum or Plasma

489

3233

1.62

19.21

8.5

5.8

mmol/l

1.0

0.20

461

2987

(3004789) Transferrin [Mass/volume] in Serum or Plasma

521

3501

1.60

19.13

3.4

2.5

g/l

2.3

0.86

492

3233

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

322

1918

1.77

18.66

5.0

3.9

ng/l

103.7

92.0

1.22

271

1630

(3007853) Bacteria identified in Skin by Aerobe culture

414

2644

1.67

18.61

2.1

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

493

3291

1.61

18.56

3.6

2.6

22.6

22.5

0.03

427

2785

(3021960) Folate [Moles/volume] in Serum or Plasma

785

5807

1.49

18.54

1.7

1.6

nmol/l

21.1

20.3

0.57

657

4921

(36304419) Bacteria [Presence] in Urine

847

6365

1.48

18.48

4.0

3.1

—

(3026008) Bacteria identified in Urine by Culture

962

7413

1.46

18.43

3.8

3.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

573

3980

1.56

18.14

4.4

3.3

mmol/l

0.8

0.13

543

3704

(3018418) pH of Serum or Plasma

933

7175

1.45

17.96

5.4

4.1

7.4

0.11

191

1363

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

436

2847

1.63

17.91

1.9

1.8

—

(3042936) Bacteria identified in Isolate by Culture

500

3382

1.58

17.73

2.5

2.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

190

976

2.02

17.38

1.6

1.5

u/ml

31.1

20.2

—

(3021589) Normoblasts [#/volume] in Blood

1231

10013

1.42

17.18

12.7

9.9

e9/l

0.0

0.43

1064

8171

(3027945) Reticulocytes/100 erythrocytes in Blood

437

2886

1.61

17.09

3.1

2.6

1.9

1.8

0.98

385

2542

(3009261) Glucose [Presence] in Urine by Test strip

1358

11263

1.41

16.81

5.2

3.9

estimate

0.0

1.08

280

2019

(40768804) Tissue Pathology biopsy report

1150

9274

1.41

16.71

2.3

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1272

10443

1.41

16.64

6.4

4.9

g/l

35.2

35.0

0.31

1180

9684

(3023520) Reticulocytes [#/volume] in Blood

348

2187

1.68

16.53

3.2

2.6

e9/l

72.4

69.7

0.53

275

1685

(3021601) Nitrite [Presence] in Urine by Test strip

1341

11121

1.40

16.49

6.7

5.2

estimate

0.0

0.50

290

2071

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

571

4049

1.52

16.23

3.3

2.8

e6/l

0.7

1.1

4.38

388

2362

(3013512) EKG study

919

7154

1.43

16.15

5.0

4.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

437

2928

1.59

16.01

1.6

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

154

755

2.10

15.99

1.3

1.2

u/ml

0.5

1.1

0.73

(3015377) Calcium [Moles/volume] in Serum or Plasma

1030

8193

1.41

15.98

3.5

3.4

mmol/l

2.4

0.17

870

7099

(3026782) Osmolality of Urine

648

4732

1.48

15.93

3.6

2.8

mosm/kgh2o

532.7

546.6

0.90

574

4033

(3017181) Myelocytes/100 leukocytes in Blood

319

1979

1.69

15.88

5.0

4.1

0.9

0.14

103

590

(3029937) Albumin [Presence] in Urine by Test strip

801

6101

1.44

15.79

5.7

4.2

estimate

0.0

1.08

276

1985

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

138

654

2.17

15.63

3.1

2.4

g/l

3.5

3.6

0.10

130

616

(3035350) Ketones [Presence] in Urine by Test strip

1333

11107

1.39

15.60

5.1

3.8

estimate

0.0

0.00

282

2053

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

647

4744

1.48

15.53

5.5

3.8

ng/l

568.1

602.9

0.04

539

3897

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

122

556

2.25

15.22

2.1

2.0

mg/l

11.0

12.0

0.72

113

503

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

287

1758

1.71

14.95

1.9

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

923

7268

1.41

14.93

4.5

3.2

u/l

30.7

38.3

2.08

871

6887

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

348

2247

1.63

14.80

3.0

2.4

ug/l

9.1

7.2

0.51

297

1974

(3025941) Bacteria identified in Stool by Culture

212

1194

1.84

14.73

1.5

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

701

5267

1.44

14.69

1.8

1.7

pmol/l

10835268.2

29471692.3

0.81

563

4350

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1305

10915

1.37

14.52

4.6

4.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

290

1800

1.68

14.37

4.8

3.9

0.6

0.05

418

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

223

1295

1.79

14.01

1.3

au/ml

34.2

54.1

—

(3009343) pH of Capillary blood

259

1571

1.72

13.97

4.0

3.7

7.4

0.04

190

(3044889) 12 lead EKG panel

1845

16366

1.39

13.94

4.9

4.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

261

1592

1.71

13.79

4.1

3.7

kpa

5.1

0.40

233

1469

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

240

1431

1.74

13.76

2.4

au/ml

29.3

24.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1630

14189

1.37

13.75

4.0

3.1

u/l

50.6

52.3

0.32

1513

13044

(3000494) Fungus identified in Specimen by Culture

394

2666

1.56

13.69

1.7

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

127

615

2.12

13.64

3.2

2.4

192.9

197.7

0.20

118

586

(3021440) Promyelocytes/100 leukocytes in Blood

296

1880

1.64

13.40

5.1

4.1

0.2

0.1

0.34

546

(3014576) Chloride [Moles/volume] in Serum or Plasma

447

3124

1.51

13.37

8.2

6.7

mmol/l

104.1

104.3

0.22

430

3054

(3036489) Thrombin time

160

850

1.94

13.31

2.6

2.0

21.7

21.6

0.09

142

758

(3044640) Blood type and Crossmatch panel - Blood

927

7422

1.38

13.18

2.8

2.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1045

8529

1.36

13.16

5.6

4.1

—

(3042733) HLA Ab [Presence] in Serum

4.79

13.07

4.6

4.3

—

(40761535) Cells panel - Urine sediment

315

2059

1.60

12.67

5.0

3.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

4.04

12.37

38.6

30.2

ug/l

7.4

7.3

0.03

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

515

3769

1.45

12.13

3.6

3.0

e6/l

2.2

2.3

0.09

331

2094

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

119

589

2.07

12.10

1.9

1.5

g/l

0.2

0.84

111

565

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

409

2862

1.50

12.09

4.6

4.1

u/l

256.6

247.7

0.57

394

2699

(40758558) Short blood count panel - Blood

746

5842

1.38

11.92

7.3

6.7

—

(3002385) Erythrocyte distribution width [Ratio]

2016

18324

1.38

11.88

26.1

18.8

13.9

13.8

1.77

1997

17888

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

121

611

2.03

11.66

1.8

1.5

g/l

1.2

0.32

114

584

(3002032) Base excess in Venous blood by calculation

342

2322

1.54

11.62

5.3

3.7

mmol/l

2.3

2.0

0.55

284

1866

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

242

1515

1.66

11.57

4.0

3.7

mmol/l

1.6

1.8

0.46

170

1130

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

213

1292

1.70

11.47

3.3

pmol/l

4.4

0.02

176

1128

(3025159) Blasts/100 leukocytes in Blood

273

1765

1.61

11.47

5.1

4.1

0.1

0.5

0.92

459

(3022145) Colonoscopy Study observation

366

2538

1.51

11.26

1.4

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

341

2331

1.53

11.22

5.3

3.7

kpa

5.9

5.8

0.33

329

2258

(3020779) Urea [Moles/volume] in Serum or Plasma

331

2249

1.54

11.20

12.4

7.4

mmol/l

11.3

10.3

1.77

314

2127

(3015235) Bicarbonate [Moles/volume] in Capillary blood

123

638

1.97

11.01

4.1

3.2

mmol/l

23.8

25.0

2.03

109

550

(3005719) IgG [Mass/volume] in Serum or Plasma

263

1703

1.60

10.97

3.0

2.8

g/l

9.8

10.5

1.99

239

1553

(3024354) Oxygen [Partial pressure] in Venous blood

287

1909

1.56

10.67

4.2

3.1

kpa

4.5

4.6

0.16

277

1845

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

441

2.15

10.61

10.6

5.4

iu/ml

485.0

746.3

0.33

(3005322) IgE [Units/volume] in Serum or Plasma

197

1196

1.70

10.58

1.4

1.2

u/ml

178.9

193.0

0.10

187

1099

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

127

681

1.91

10.33

2.9

2.2

91.7

89.9

0.33

117

648

(3014111) Lactate [Moles/volume] in Serum or Plasma

315

2165

1.51

10.07

8.8

6.7

mmol/l

1.3

1.4

0.30

301

2089

(3033658) Prothrombin time (PT) actual/Normal

739

5915

1.34

9.95

5.3

4.0

84.1

88.3

3.56

717

5770

(3004119) Hemoglobin [Mass/volume] in Venous blood

234

1520

1.59

9.63

4.7

3.1

g/l

127.9

0.01

226

1478

(36660697) Celiac disease serology panel - Serum

245

1619

1.56

9.36

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

151

882

1.75

9.34

3.5

3.0

u/ml

0.3

1.01

511

(3011985) Renin [Units/volume] in Plasma

300

2.30

9.28

2.0

1.3

mu/l

107.2

57.6

0.55

266

(3024139) IgG subclass 3 [Mass/volume] in Serum

191

2.65

9.27

1.6

1.3

g/l

0.4

0.51

135

(3027135) IgG subclass 1 [Mass/volume] in Serum

191

2.65

9.27

1.6

1.3

g/l

6.5

7.1

0.60

134

(3028192) IgG subclass 2 [Mass/volume] in Serum

191

2.65

9.27

1.6

1.3

g/l

2.9

0.02

134

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

202

1281

1.62

9.18

2.5

2.4

—

(3049717) Cytology report of Urine Cyto stain

162

974

1.70

9.04

2.8

2.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

118

647

1.86

9.00

1.8

—

(4062490)

194

2.61

9.00

1.6

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

910

7595

1.30

8.88

3.9

3.2

mmol/l

7.1

7.3

0.71

760

6343

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

145

851

1.74

8.83

3.3

2.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

113

616

1.87

8.78

2.1

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

132

757

1.78

8.71

1.4

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

147

870

1.73

8.70

2.7

2.2

ug/l

219.1

793.8

1.70

136

817

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

313

2214

1.47

8.66

3.8

2.9

ng/l

248.5

214.1

0.58

285

2031

(3012516) Albumin [Mass/volume] in Urine

879

7323

1.29

8.65

3.9

3.2

mg/l

500.5

293.8

0.58

562

4630

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

187

1183

1.62

8.60

2.0

1.7

g/l

1.5

0.15

165

1017

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

183

2.60

8.42

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

625

4986

1.33

8.41

5.5

4.3

kg/l

1.0

0.42

765

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

170

1057

1.65

8.38

2.0

1.9

ug/l

3.4

2.3

0.30

153

931

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

191

2.54

8.24

2.2

2.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

445

1.99

8.19

3.2

3.5

57.7

57.8

0.01

445

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

115

646

1.81

8.15

1.6

iu/ml

15.3

10.1

0.12

135

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

111

618

1.83

8.10

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

120

685

1.79

8.06

1.5

1.4

ug/g

244.0

280.9

1.35

407

(3016502) Oxygen saturation in Arterial blood

355

2607

1.42

8.01

9.0

7.4

95.4

95.5

0.15

339

2510

(3041096) Erythrocytes [Presence] in Urine by Automated

714

5838

1.30

7.98

4.9

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

286

2020

1.46

7.97

4.2

4.0

mmol/l

1.2

0.17

255

1760

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

701

5720

1.30

7.95

2.6

2.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

317

2.14

7.78

1.6

g/l

0.6

0.9

2.88

243

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

741

6108

1.29

7.75

1.7

1.6

mmol/l

1.3

1.4

0.82

612

5083

(3028626) Oxygen [Partial pressure] in Capillary blood

105

584

1.83

7.70

3.4

3.3

kpa

8.4

8.0

1.23

537

(3017732) Neutrophils [#/volume] in Blood

228

1550

1.51

7.67

3.8

3.2

e9/l

3.9

4.1

0.47

154

1181

(3027273) Bicarbonate [Moles/volume] in Venous blood

189

1234

1.57

7.63

4.7

3.2

mmol/l

25.7

25.3

0.76

183

1193

(3020682) Albumin/Creatinine [Ratio] in Urine

911

7726

1.27

7.54

4.8

4.0

mg/mmol

12.6

8.8

1.23

569

4851

(3003327) Ova and parasites identified in Stool by Light microscopy

107

606

1.80

7.41

1.8

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

284

2.17

7.39

1.5

1.3

pmol/l

346.8

290.4

0.43

220

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

273

1947

1.45

7.23

3.2

2.7

ml/min/173m2

58.2

62.9

1.13

118

803

(3014765) Yersinia sp identified in Stool by Organism specific culture

112

651

1.75

7.11

1.4

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

406

1.95

7.03

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

111

646

1.75

7.02

1.4

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

213

1455

1.50

7.02

1.6

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

192

1283

1.53

7.01

1.2

iu/ml

157.0

142.3

0.18

468

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.16

6.98

1.6

2.1

ug/l

23.6

113.0

0.48

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

224

1548

1.49

6.97

1.7

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

350

2626

1.38

6.94

4.1

2.7

umol/l

6.4

8.6

3.65

306

2298

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

560

1.80

6.91

1.3

1.2

u/ml

26.9

31.3

—

(3019225) pH of Specimen

334

2489

1.39

6.90

5.3

4.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

103

591

1.77

6.85

1.8

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

519

1.82

6.79

1.9

1.8

iu/l

5.7

4.4

0.34

161

(3003396) Base excess in Arterial blood by calculation

380

2904

1.36

6.71

8.7

7.1

mmol/l

1.3

1.2

0.21

302

2267

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.15

6.71

3.5

2.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.71

6.68

1.0

1.1

86.8

81.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.71

6.68

1.1

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

290

2.09

6.65

1.5

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

111

657

1.72

6.64

1.4

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

288

2109

1.41

6.59

1.8

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

172

1142

1.54

6.48

4.1

2.6

1.3

1.2

0.74

172

1133

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

527

1.79

6.47

1.3

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

380

2920

1.35

6.47

8.8

7.1

kpa

5.0

5.1

0.93

360

2785

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.08

6.46

7.2

6.8

mg/l

8003.4

63.5

0.48

(3002173) Hemoglobin [Mass/volume] in Arterial blood

319

2386

1.38

6.44

9.7

7.9

g/l

118.8

120.8

0.96

307

2298

(3014148) Varicella zoster virus Ab [Titer] in Serum

196

2.32

6.43

1.0

1.1

—

(3000991) Gas panel - Venous blood

279

2042

1.41

6.41

10.9

8.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

142

2.56

6.36

1.1

1.2

u/ml

0.1

1.2

0.90

(3022313) Gas panel - Capillary blood

171

1139

1.53

6.36

4.4

3.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

379

2920

1.35

6.34

8.8

7.1

kpa

11.8

12.1

0.46

363

2784

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

577

1.74

6.27

1.8

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

916

7902

1.24

6.27

5.8

5.2

ug/l

2.6

3.2

1.08

809

7058

(3008898) HLA-B27 [Presence]

100

585

1.74

6.25

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2121

19989

1.27

6.21

22.7

16.7

39.2

0.09

1381

13392

(46235355) HIV 1 and 2 tests - Meaningful Use set

360

2762

1.35

6.19

2.0

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

167

1115

1.53

6.15

4.1

2.6

0.6

0.7

0.42

157

1071

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

169

1132

1.53

6.13

2.1

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

362

1.93

6.12

1.4

u/ml

103.5

115.6

0.59

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

457

1.82

6.05

1.1

1.3

—

290.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

196

1358

1.48

6.05

1.7

1.8

g/l

1.1

1.4

3.39

180

1226

(3004716) Salmonella sp identified in Stool by Organism specific culture

150

986

1.55

5.94

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

338

1.95

5.93

8.5

6.7

mg/l

12.8

12.0

0.47

320

(40768446) Kidney Pathology biopsy report

3.06

5.92

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

312

2358

1.36

5.91

1.8

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

166

2.37

5.89

1.2

titre

62.0

128.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

568

1.72

5.79

1.6

1.7

e6/l

10612.5

15503.1

0.84

400

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

546

1.73

5.77

1.7

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.39

5.76

1.0

1.1

80.0

83.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

399

1.85

5.75

1.5

1.4

—

(3024471) HLA-A [Type]

3.16

5.74

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.35

5.72

1.0

1.4

86.1

84.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.35

5.72

1.0

1.1

80.4

87.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

379

1.87

5.68

1.4

1.2

u/ml

43.8

49.5

0.11

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

182

1260

1.48

5.65

2.1

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

645

5404

1.25

5.65

4.9

3.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

150

998

1.53

5.64

1.1

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

461

1.78

5.60

1.9

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

156

1050

1.51

5.56

5.0

5.4

1.6

0.20

149

977

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

330

2540

1.34

5.55

4.2

3.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

270

2.02

5.53

1.6

66.3

64.4

0.14

167

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

531

1.72

5.50

1.3

1.2

u/ml

23.5

8.0

—

(4198724)

3.48

5.45

1.7

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

519

1.72

5.39

3.8

2.8

umol/l

33.6

37.1

0.58

432

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

111

697

1.62

5.36

2.0

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.56

5.32

1.1

1.0

—

(3045414) Leukocytes [Presence] in Urine

154

1044

1.50

5.32

2.0

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

187

2.21

5.32

2.4

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

181

2.23

5.29

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

440

1.77

5.27

1.2

u/ml

4.2

2.7

—

(3016879) Cocaine [Presence] in Urine

396

1.81

5.27

1.9

2.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

552

4578

1.26

5.24

2.9

3.1

mmol/l

2.5

0.75

479

4025

(3024932) HLA-DR beta [Type]

3.06

5.22

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

333

1.88

5.19

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

242

1795

1.38

5.16

2.2

2.4

—

(3021901) Oxygen saturation in Capillary blood

466

1.74

5.14

3.0

2.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

244

2.03

5.10

1.3

u/ml

48.4

54.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.21

5.09

21.5

15.1

mmol/l

6.8

5.5

0.59

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

423

1.77

5.08

1.6

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

522

1.69

5.03

1.3

1.2

u/ml

1.9

4.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.41

5.02

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

152

1041

1.49

5.01

5.1

5.5

0.9

0.22

145

970

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

366

1.82

5.01

1.5

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

739

6355

1.22

5.00

5.0

4.5

21.8

0.00

372

3237

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

274

2084

1.35

4.99

3.0

2.4

u/l

86.7

39.5

0.48

239

1774

(3035637) Corticotropin [Mass/volume] in Plasma

267

1.97

4.98

1.6

1.4

—

(3021788) Differential panel - Synovial fluid

411

1.77

4.97

1.6

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

105

2.59

4.96

2.1

2.5

u/ml

3092.0

1255.0

0.56

105

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

353

1.83

4.94

1.8

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

427

1.75

4.93

1.9

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

339

1.85

4.93

1.7

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

541

1.67

4.91

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

488

1.70

4.90

1.5

1.6

—

(3028300) Cannabinoids [Presence] in Urine

429

1.74

4.85

1.9

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

582

1.64

4.84

3.7

3.2

nmol/l

0.8

0.72

450

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

166

1166

1.45

4.82

5.6

4.2

mmol/l

24.3

24.1

0.19

143

1044

(4010399)

222

1643

1.38

4.81

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

364

1.80

4.79

1.2

u/ml

343.4

266.1

1.15

217

(1616796) Gas panel - Central venous blood

563

1.64

4.71

4.2

3.9

—

(40767503) Oxygen content in Capillary blood by calculation

540

1.65

4.70

2.5

16.2

15.9

0.30

269

(1001926) Buprenorphine [Presence] in Urine by Screen method

330

1.84

4.70

2.0

—

(3027944) Amphetamines [Presence] in Urine

419

1.74

4.67

1.9

—

(3027008) Opiates [Presence] in Urine

428

1.72

4.62

1.8

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

217

1612

1.38

4.60

8.1

6.9

mmol/l

24.8

24.6

0.26

196

1500

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

318

1.84

4.59

1.5

1.4

—

(3023419) Bacteria identified in Sputum by Culture

328

1.82

4.48

3.5

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

206

1525

1.38

4.47

2.4

2.2

nmol/l

11.7

12.5

0.61

180

1335

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

440

1.70

4.47

1.9

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

162

2.18

4.43

2.2

—

(3009871) Measles virus Ab [Titer] in Serum

3.01

4.39

1.6

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

142

988

1.46

4.36

4.3

4.0

mmol/l

24.7

24.8

0.09

130

915

(3052851) Hemolysis interference index of Serum or Plasma

109

719

1.54

4.33

3.9

3.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

211

2.01

4.31

1.6

1.5

27.9

28.4

0.03

135

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

232

1.96

4.30

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

577

1.60

4.29

2.0

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

101

2.49

4.29

1.2

—

(40768443) Skin Pathology biopsy report

142

993

1.45

4.26

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

182

1332

1.39

4.24

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.62

4.20

1.5

1.3

ng/l

95.1

93.2

0.03

(3045424) Erythrocytes [Presence] in Urine

395

1.71

4.19

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

285

1.84

4.15

2.0

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

544

1.60

4.11

2.3

2.2

g/l

127.4

127.9

0.07

398

(40759836) Histone Ab [Presence] in Serum by Immunoblot

135

2.24

4.08

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

135

2.24

4.08

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

135

2.24

4.08

1.2

—

(3000492) Spirometry study

256

1988

1.32

4.07

1.6

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

111

2.36

3.99

3.9

3.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

137

2.20

3.95

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

2.20

3.95

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

137

2.20

3.95

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.43

3.90

1.1

1.2

—

(3019060) Gas panel - Arterial blood

224

1719

1.33

3.88

5.3

4.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

135

954

1.44

3.86

2.1

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

390

1.68

3.84

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

197

1487

1.35

3.82

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

286

1.80

3.81

1.1

1.3

nmol/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

272

2151

1.29

3.79

2.2

2.6

g/l

65.5

66.3

1.13

252

1963

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

243

1.87

3.79

1.5

1.6

—

(3019977) pH of Arterial blood

134

2.18

3.73

1.8

2.8

7.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

223

1.90

3.73

1.3

e6/l

60067.3

96614.2

0.22

154

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

177

1320

1.36

3.71

11.2

9.0

mmol/l

24.5

24.4

0.11

159

1239

(3024891) Influenza virus A+B Ag [Presence] in Specimen

536

1.57

3.67

1.2

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

404

1.65

3.64

3.5

3.6

0.9

1.4

1.00

310

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.43

3.63

2.0

ug/l

71.8

55.5

0.34

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

337

1.71

3.58

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.05

3.53

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

264

1.79

3.52

1.4

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.86

3.52

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.56

3.48

7.7

5.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

600

1.52

3.47

1.2

titre

206.3

91.7

—

(3002256) Pathology report gross observation

371

3082

1.24

3.43

1.3

—

(40761536) Microorganisms panel - Urine sediment

243

1925

1.29

3.37

6.1

4.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

147

2.05

3.36

3.0

2.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

114

2.20

3.35

1.3

1.4

nmol/l

1.0

1.1

0.20

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

177

1343

1.34

3.35

1.4

1.3

—

(3003338) MCHC [Mass/volume]

1940

18493

1.17

3.34

28.8

20.2

g/l

331.4

331.9

1.34

1926

18342

(3044941) Cell count panel - Synovial fluid

383

1.63

3.33

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.93

3.30

2.9

3.5

au/ml

149.5

36.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

169

1.96

3.29

2.0

2.2

16.2

13.5

0.45

(44790049)

278

1.74

3.27

1.8

1.5

—

(44790048)

278

1.74

3.27

1.8

1.5

—

(44790047)

278

1.74

3.27

1.8

1.5

—

(44806118)

278

1.74

3.27

1.8

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

2.10

3.23

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

220

1.83

3.23

1.9

2.3

e9/l

1.3

1.1

0.87

129

(3010421) pH of Blood

668

1.47

3.23

4.9

4.5

7.4

0.35

555

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

349

2900

1.23

3.22

1.4

—

(3012501) Base excess in Blood by calculation

562

1.51

3.21

4.5

4.8

mmol/l

2.7

0.05

393

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

185

1.90

3.19

2.4

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.74

3.15

3.9

3.1

—

(3042631) Mycobacterium sp identified in Specimen

343

1.65

3.12

3.0

2.7

—

(3028433) Virus identified in Specimen by Culture

2.48

3.12

1.1

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

114

815

1.42

3.12

3.0

3.3

ratio

1.3

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.29

3.10

1.5

2.6

umol/l

78.5

151.0

0.90

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

140

1039

1.37

3.08

2.2

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

536

1.51

3.06

1.5

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.44

3.04

1.1

miu/ml

1590.8

1651.4

0.08

(3047181) Lactate [Moles/volume] in Blood

111

795

1.41

3.02

6.0

6.5

mmol/l

1.3

0.12

100

688

(40768441) Liver Pathology biopsy report

168

1.92

2.99

2.1

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

418

1.57

2.99

4.1

3.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

4.30

2.99

15.4

14.6

—

(3011288) Drugs identified in Urine by Screen method

286

1.69

2.98

2.2

3.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

360

3026

1.22

2.98

5.3

4.7

33.2

33.0

0.15

243

1991

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.36

2.98

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

101

2.19

2.93

1.1

—

(3025315) Body weight

4.72

2.92

3.4

4.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

2.90

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

163

1.91

2.90

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.38

2.89

2.1

2.4

30.5

28.8

0.17

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.70

2.88

3.2

4.1

mg/l

12.1

8.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.10

2.88

2.7

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

391

1.57

2.86

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

512

1.50

2.85

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

512

1.50

2.85

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

280

2308

1.24

2.81

2.6

2.2

g/l

0.2

0.41

258

2142

(3020191) Ethanol [Moles/volume] in Serum or Plasma

158

1.91

2.80

1.3

1.4

promille

1.4

1.1

0.45

116

(4034850)

107

774

1.40

2.77

15.0

10.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.27

2.77

2.7

2.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

316

1.63

2.76

1.2

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

124

2.03

2.76

2.0

2.7

37.3

38.8

0.14

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

105

758

1.40

2.76

1.7

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

8.35

2.75

1.8

2.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

309

1.63

2.73

1.2

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

248

1.70

2.72

3.8

3.6

52.7

56.5

0.41

158

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

349

1.59

2.71

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.43

2.71

1.6

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

364

3095

1.20

2.69

9.5

7.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

303

1.63

2.68

1.4

1.2

u/ml

4.2

4.3

0.02

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

311

1.62

2.67

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

311

1.62

2.67

1.2

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.40

2.63

1.8

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.40

2.63

1.8

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

114

842

1.37

2.63

3.0

3.3

mg/l

35.7

73.3

1.38

681

(3034860) Kappa light chains.free [Mass/volume] in Serum

114

844

1.37

2.59

3.0

3.3

mg/l

40.9

128.8

0.71

681

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.46

2.54

6.0

5.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

274

2280

1.22

2.53

1.9

1.8

1.5

0.77

229

1960

(3025468) Yersinia sp identified in Specimen by Organism specific culture

308

1.60

2.53

1.2

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.61

2.53

1.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

302

1.60

2.47

1.2

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

106

783

1.37

2.46

5.4

3.9

mmol/l

3.9

0.47

735

(3022621) pH of Urine by Test strip

195

1569

1.26

2.45

3.4

3.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

138

1.89

2.41

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

117

1.97

2.40

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

117

1.97

2.40

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

117

1.97

2.40

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

117

1.97

2.40

1.4

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.01

2.40

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

115

865

1.34

2.39

3.8

3.2

g/l

0.4

0.3

0.56

351

(3024522) Salmonella sp identified in Specimen by Organism specific culture

313

1.58

2.38

1.2

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

644

1.39

2.35

3.1

3.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

206

1.71

2.34

1.5

1.3

u/l

37.1

28.8

0.63

167

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.10

2.32

1.4

1.7

nmol/l

2.9

11.3

0.89

(3051651) Icteric interference index of Serum or Plasma

148

1.83

2.28

4.7

3.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.46

2.27

1.8

2.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

208

1.69

2.27

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

208

1.69

2.27

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

208

1.69

2.27

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

295

1.57

2.22

1.4

1.2

u/ml

6.3

5.2

0.13

132

(3004616) Nuclear Ab [Presence] in Serum

272

1.59

2.20

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

501

1.43

2.18

5.2

3.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

137

1.83

2.13

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

355

1.50

2.12

2.0

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1006

1.30

2.11

2.6

2.3

g/l

3.6

3.8

1.06

724

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

205

1.67

2.11

2.0

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

598

1.38

2.10

1.5

1.4

iu/l

27.3

32.2

0.64

512

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1008

1.29

2.09

2.7

2.4

g/l

7.2

7.4

0.91

759

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1008

1.29

2.09

2.6

2.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.91

2.07

1.4

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

5.01

2.07

1.2

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

524

1.40

2.06

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

524

1.40

2.06

1.4

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.18

2.04

1.3

1.2

g/l

34.2

38.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

4.01

2.04

1.0

1.2

—

(3004451) EKG impression Narrative

132

1.83

2.03

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

125

1.85

2.02

1.1

u/l

11.3

31.1

3.07

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

942

1.30

2.02

2.7

2.3

g/l

9.5

10.3

1.23

101

801

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.08

2.01

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

629

1.36

2.01

1.9

1.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.01

2.00

1.1

1.2

iu/ml

322.6

223.4

0.27

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

508

4551

1.14

1.97

3.5

3.1

ug/l

0.7

0.8

3.77

349

3141

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

141

1.78

1.96

1.7

2.4

e9/l

0.2

0.30

123

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

362

1.47

1.96

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.19

1.94

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.55

1.94

1.2

1.5

—

(3024263) Appearance of Synovial fluid

127

1.82

1.94

1.5

1.8

—

(3020891) Body temperature

131

1039

1.27

1.91

6.5

4.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

165

1.70

1.91

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

311

2695

1.17

1.89

3.2

4.0

ug/l

7.8

23.2

2.46

247

2220

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.16

1.88

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.16

1.88

1.7

1.2

ug/l

12.3

8.9

1.23

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

690

1.33

1.86

1.9

1.7

mg/l

3.6

3.8

0.04

504

(3052592) Norovirus Ag [Presence] in Stool

2.40

1.85

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.53

1.83

1.0

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

278

1.52

1.82

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.89

1.80

1.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

132

1057

1.26

1.80

1.8

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

161

1.68

1.78

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

471

1.39

1.77

1.3

1.8

nmol/l

0.8

0.30

387

(3051611) Lipemic interference index of Serum or Plasma

264

1.52

1.76

4.5

3.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.94

1.74

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.23

1.74

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

125

1.77

1.71

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.14

1.71

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

266

1.51

1.71

4.1

3.9

—

(40768793) Breast Pathology biopsy report

541

0.66

1.71

1.5

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

133

1.74

1.69

1.7

—

(4146454)

275

1.50

1.69

2.8

2.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

164

1359

1.22

1.66

12.9

9.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.25

1.63

1.0

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

245

1.52

1.62

1.3

1.2

u/l

50.3

58.1

0.95

169

(3044242) Glucose [Moles/volume] in Arterial blood

135

1.71

1.62

2.9

2.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.58

1.61

1.6

1.9

mg/l

31.0

21.6

—

(3002619) Bacteria identified in Specimen by Culture

2.33

1.60

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

939

1.26

1.59

2.5

2.4

g/l

2.9

3.1

1.32

743

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

206

1.56

1.59

1.7

1.1

—

(4268621)

206

1.56

1.59

2.6

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

542

1.34

1.58

1.1

u/ml

10.0

5.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

191

1.58

1.57

2.7

1.4

u/ml

28.0

21.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

305

1.45

1.56

1.1

—

(3000330) Specific gravity of Urine by Test strip

152

1259

1.22

1.56

5.3

3.6

—

(1002224) Polysomnography panel

737

1.29

1.55

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

449

1.37

1.55

1.2

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.04

1.54

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.04

1.54

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

115

1.74

1.52

1.4

1.2

nmol/l

138.8

139.9

0.05

115

(3009214) Lutropin [Units/volume] in Serum or Plasma

417

1.37

1.51

1.5

1.3

u/l

14.3

10.3

1.16

336

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

1.50

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.16

1.50

1.5

—

(3044927) Protein electrophoresis panel - Urine

275

1.46

1.49

1.3

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

131

1.68

1.49

3.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

131

1.68

1.49

3.8

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.90

1.49

2.1

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

178

1.58

1.48

2.0

1.4

nmol/l

0.3

0.05

132

(3032773) Endomysium IgG Ab [Titer] in Serum

155

1.62

1.46

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

327

1.41

1.45

3.3

2.3

mg/l

17.7

22.7

—

(44806071)

2.73

1.43

1.5

1.1

—

(3045716) Anion gap in Serum or Plasma

125

1.69

1.43

3.5

2.5

mmol/l

9.2

9.6

0.12

102

(3000012) Reticulocyte production index

141

1.64

1.41

1.5

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

2.42

1.39

1.7

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.61

1.36

1.3

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

253

2222

1.15

1.35

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

151

1.59

1.34

1.2

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.15

1.33

1.0

1.2

—

(4015189)

1.92

1.33

4.6

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

781

1.25

1.33

2.2

2.1

g/l

38.2

37.7

0.29

675

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.78

1.33

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

113

1.69

1.31

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

113

1.69

1.31

1.2

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.76

1.29

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

153

1.57

1.28

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

122

1.64

1.27

1.3

1.7

u/field

2.1

0.00

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.72

1.27

1.4

1.2

—

68.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.72

1.27

1.3

1.4

umol/l

24.5

23.9

0.03

(3014051) Protein [Presence] in Urine by Test strip

554

1.29

1.26

2.3

2.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

652

1.27

1.26

7.1

4.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

294

1.40

1.26

1.2

1.1

103.7

114.7

1.08

270

(3016650) Hepatitis A virus Ab [Presence] in Serum

328

1.38

1.26

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

423

1.33

1.26

1.1

1.2

u/l

51.0

38.5

0.28

364

(3000093) Morphology [Interpretation] in Blood Narrative

219

1.47

1.25

1.5

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.82

1.25

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.40

1.24

1.7

1.3

—

706.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

228

1.45

1.24

2.5

2.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.91

1.22

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

196

1.48

1.21

1.3

1.2

nmol/l

356.7

367.9

0.09

166

(3017315) Amylase [Enzymatic activity/volume] in Urine

116

1.64

1.21

1.3

u/l

188.5

412.9

1.18

106

(3034426) Prothrombin time (PT)

1.88

1.18

1.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

141

1.56

1.17

2.1

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

342

1.35

1.16

2.2

2.0

u/l

2119.8

3310.6

0.22

139

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

343

1.35

1.14

1.0

1.1

—

(3016750) Collection duration of Urine

150

1.54

1.14

2.9

2.0

min

500.1

491.8

0.13

109

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.00

1.12

1.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

151

1.53

1.11

1.4

2.2

e6/l

599.7

694.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.96

1.11

1.0

1.1

umol/24h

0.3

0.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.78

1.10

1.7

2.4

ug/l

1.0

1.7

0.92

(1761868) Lipid panel - Serum or Plasma

766

7230

1.08

1.10

3.5

3.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

137

0.51

1.09

1.1

—

(3005033) Fetal Nuchal fold Thickness US

138

0.51

1.09

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

139

0.50

1.09

1.6

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

1.50

1.09

1.2

—

(3018572) Chloride [Moles/volume] in Blood

567

1.26

1.09

7.1

7.5

mmol/l

105.6

105.4

0.15

500

(3039000) Anion gap in Blood

567

1.26

1.09

7.1

7.5

mmol/l

11.4

11.2

0.21

500

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

120

1.59

1.08

1.2

1.1

u/l

1.4

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

270

1.38

1.06

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

105

1.62

1.06

2.2

1.4

4.3

1.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

186

1.46

1.06

1.2

1.1

—

72.5

—

(3014271) Vancomycin [Susceptibility]

129

1.55

1.05

2.8

3.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

178

1.47

1.05

1.2

1.1

—

4.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

229

1.40

1.03

1.2

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.96

1.03

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

996

0.82

1.02

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.84

1.02

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.84

1.02

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.84

1.02

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.84

1.02

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

307

1.34

1.02

2.6

2.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.89

1.01

5.2

8.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

115

1.57

0.99

1.4

1.1

ratio

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

115

1.57

0.99

1.1

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

326

1.32

0.99

5.0

5.1

umol/l

334.9

363.1

0.57

278

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.81

0.98

4.8

8.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.97

0.0

1.2

—

21.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.97

0.0

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

585

1.24

0.97

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

141

1.49

0.94

2.1

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

453

1.26

0.94

1.3

1.2

miu/ml

194.3

216.5

0.18

183

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

133

1150

1.16

0.94

2.4

3.7

u/ml

54.8

69.1

0.30

124

1108

(3043238) Trisomy 21 risk [Likelihood] in Fetus

144

0.55

0.93

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

295

1.33

0.92

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

330

1.31

0.92

1.4

e6/l

1308.5

1600.2

0.31

238

(21494814) CD8 cells/100 lymphocytes in Specimen

1.60

0.90

2.0

2.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

151

1.46

0.90

1.4

1.3

—

71.9

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

2.07

0.89

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

202

1.39

0.89

1.0

u/ml

5.0

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.91

0.88

1.4

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.79

0.87

1.9

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.00

0.87

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.00

0.87

2.0

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

1.43

0.86

2.0

1.5

—

(3017569) Oxygen content in Arterial blood

128

1.49

0.86

3.4

2.3

—

(4094501)

587

1.22

0.84

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

1.54

0.84

1.3

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.76

0.83

1.1

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

154

1.43

0.83

1.6

u/l

5.2

5.8

0.12

(3039443) Prostate specific Ag panel - Serum or Plasma

399

0.75

0.82

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

444

1.24

0.82

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

100

857

1.17

0.81

2.5

2.4

g/l

0.4

1.0

2.03

747

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

134

1524

0.87

0.81

1.9

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

293

1.30

0.81

1.5

1.4

e6/l

30031.6

88574.3

1.20

170

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.55

0.81

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.58

0.81

1.4

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.58

0.81

1.4

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

130

1.46

0.80

4.8

14.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

250

1.32

0.80

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

224

0.67

0.80

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

233

1.33

0.79

1.4

1.6

—

1506.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.78

0.0

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

251

1.32

0.78

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

123

1402

0.87

0.78

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.62

0.78

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.76

0.0

4.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.76

0.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.70

0.75

1.4

1.0

pmol/l

308.4

270.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.70

0.75

1.0

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.54

0.75

1.4

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.75

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.60

0.75

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.09

0.74

5.2

1.8

umol/l

21.6

18.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.09

0.74

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.67

0.74

1.8

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

272

1.29

0.72

1.0

1.1

u/ml

1.8

1.7

0.01

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

0.72

1.6

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

0.72

1.6

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

0.72

1.6

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

142

1.41

0.72

2.1

1.5

g/l

0.9

1.0

1.09

142

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

299

1.27

0.72

2.4

2.3

u/ml

33.5

1064.7

0.61

288

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.71

1.0

1.1

—

(4027681)

109

1.47

0.71

1.4

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.92

0.70

1.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

267

1.28

0.66

1.8

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.79

0.66

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

232

1.30

0.66

1.0

1.1

u/ml

9.0

3.2

0.74

103

(4306422)

304

1.25

0.65

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

178

0.67

0.64

1.3

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

233

1.29

0.64

1.1

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

199

1.31

0.62

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.55

0.62

1.2

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

173

1.33

0.61

1.3

1.2

—

(3036603) Volume of Urine

147

1.36

0.61

1.5

1.4

1596.2

1775.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.48

0.60

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

210

1.29

0.58

2.8

5.3

u/ml

48.5

57.0

—

(3022689) Creatine [Moles/volume] in Urine

1.56

0.58

1.7

1.5

—

(3004775) Volume in Urine collected for unspecified duration

202

1.29

0.57

2.8

2.2

648.0

625.5

0.10

132

(3006922) Hepatitis E virus Ab [Presence] in Serum

132

1.37

0.57

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

0.58

0.56

1.4

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

203

1.28

0.55

1.3

2.1

u/field

0.9

2.0

1.30

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.45

0.55

1.2

1.1

—

7.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.47

0.54

1.0

1.1

—

(3017704) Immunofixation for Urine

151

1.33

0.54

1.2

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

125

1.36

0.53

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

125

1.36

0.53

1.2

1.0

—

(44813793)

134

1.35

0.53

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.52

0.52

1.4

2.0

—

(3008295) Osmolality of Serum or Plasma

259

1.24

0.52

1.4

mosm/kgh2o

281.5

276.9

0.32

195

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.50

0.51

1.5

1.2

—

(3037756) Immunofixation for Serum or Plasma

565

1.15

0.51

1.4

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

215

1.26

0.51

1.4

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.39

0.50

1.1

1.2

—

16.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.46

0.50

6.8

7.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

136

1.33

0.49

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.56

0.49

3.3

5.8

—

(3035880) pH of Pleural fluid

155

0.71

0.48

1.7

1.4

—

(3003181) Sodium [Moles/volume] in Urine

466

1.16

0.47

1.3

mmol/l

68.5

64.8

0.26

373

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

165

0.73

0.46

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

165

0.73

0.46

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

273

1.21

0.46

4.4

4.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

164

0.73

0.45

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

164

0.73

0.45

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

610

1.13

0.44

2.8

2.3

ug/min

83.1

99.2

0.18

370

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

611

1.13

0.43

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

166

1.27

0.43

1.1

1.2

mmol/l

35.6

33.7

0.15

143

(4035726)

230

2162

1.07

0.43

1.5

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.61

0.43

1.0

1.2

umol/24h

1.4

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

499

1.15

0.43

1.2

1.5

e6/l

3.7

25.1

1.31

388

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

499

1.15

0.43

1.2

1.6

e6/l

277.1

1001.6

1.39

408

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

565

1.14

0.42

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

151

0.73

0.42

1.5

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.41

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

105

1.34

0.41

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.1

—

33.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

114

1.32

0.40

1.0

1.1

—

(21494434) Karyotype in Bone marrow

250

1.20

0.40

1.4

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.40

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

141

1.28

0.40

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.39

1.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

105

0.67

0.39

1.0

5.3

—

63.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

1.28

0.38

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

143

1.26

0.37

1.0

u/ml

0.1

0.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

135

0.74

0.36

2.0

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

235

1.19

0.36

2.0

2.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

226

1.20

0.35

1.0

1.1

u/ml

0.4

2.5

1.42

(40768800) Prostate Pathology biopsy report

517

1.12

0.35

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

282

1.17

0.35

1.8

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

218

1.19

0.34

3.8

3.1

mg/l

84.6

31.9

0.57

164

(3023430) Cat dander IgE Ab [Units/volume] in Serum

163

1.23

0.34

1.0

1.1

u/ml

3.0

2.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

246

1.18

0.34

1.2

1.3

mmol/l

7.1

7.5

0.18

177

(3003694) ABO and Rh group [Type] in Blood

610

5928

1.04

0.34

1.4

1.3

—

(40765096) Chromosome analysis panel by Banding

0.69

0.33

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

303

1.16

0.33

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.28

0.32

1.0

1.3

—

(3012441) Differential panel - Pleural fluid

277

1.16

0.30

1.8

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

129

1.24

0.30

1.1

1.4

pmol/l

56.4

278.7

—

(3005570) Glucose [Moles/volume] in Urine

250

0.84

0.30

1.4

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

919

1.08

0.29

2.6

3.3

u/ml

18.2

4645.2

0.90

779

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

148

1.22

0.29

2.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

186

1.18

0.28

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.21

0.26

1.3

1.0

—

(3020650) Glucose [Presence] in Urine

1.21

0.26

1.6

—

(4281824)

254

1.14

0.25

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

170

0.82

0.25

1.9

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.18

0.24

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.27

0.24

1.1

1.7

umol/l

1.7

2.0

0.43

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

133

1.20

0.24

4.5

3.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

218

1.15

0.23

1.6

1.8

—

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.25

0.22

1.4

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

240

1.13

0.20

1.2

1.1

—

(4211845)

113

0.80

0.20

4.7

3.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

241

1.12

0.19

1.7

1.3

u/l

257.0

327.9

0.55

230

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

1.16

0.17

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.11

0.17

1.3

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

177

1.13

0.16

1.0

u/ml

5.5

2.1

—

(3023410) Appearance of Cerebral spinal fluid

225

0.89

0.16

1.3

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

111

1.17

0.15

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

149

1.14

0.15

4.0

6.7

—

(3045788) Cell count panel - Pleural fluid

264

1.10

0.15

1.4

—

(3048879) Bone marrow aspiration report

0.76

0.15

1.5

1.6

—

(3011648) Oxygen content in Venous blood

178

1.12

0.15

2.8

2.9

11.4

11.1

0.08

178

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

226

1.11

0.15

1.5

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

104

1.15

0.12

2.2

2.3

umol/l

45.6

51.8

—

(3033799) Differential panel - Peritoneal fluid

1.18

0.12

2.7

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

158

0.89

0.12

1.4

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

126

0.87

0.11

2.5

2.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

280

0.93

0.10

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.11

0.09

1.4

2.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.04

0.09

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

262

1.07

0.09

1.0

1.1

u/ml

1.3

2.1

1.22

106

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.11

0.09

2.0

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

826

0.97

0.08

1.9

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.03

0.08

2.2

2.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

144

0.90

0.08

1.1

1.3

mmol/l

12.4

12.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.79

0.08

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

195

0.92

0.08

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

205

1.07

0.08

1.6

1.5

—

(3020491) Glucose [Moles/volume] in Blood

176

1.08

0.07

1.8

2.2

mmol/l

7.3

7.0

0.25

115

(44806420)

0.85

0.07

2.3

2.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.06

0.07

1.9

1.4

mmol/l

2.1

3.1

—

(3006462) Nitrate [Presence] in Urine

105

0.86

0.06

4.7

4.0

—

(4024509)

246

1.06

0.06

1.8

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

142

1.06

0.02

2.4

2.1

ug/min

147.0

181.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

351

1.03

0.02

1.1

iu/ml

53.1

93.8

—

(3047189) Immunofixation for 24 hour Urine

116

0.95

0.00

2.0

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

316

0.98

0.00

1.8

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

105

1.05

0.00

12.6

13.8

nmol/l

761.6

774.0

0.03

(3051387) C reactive protein [Mass/volume] in Capillary blood

541

1.00

0.00

4.0

3.5

mg/l

30.5

28.0

0.14

337

(3045683) HLA typing for celiac disease panel - Blood or Tissue

103

0.97

0.00

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

187

1.02

0.00

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.01

0.00

1.0

2.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

110

1.00

0.00

1.7

1.5

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.98

0.00

1.6

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.00

0.00

1.0

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

13.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.95

0.00

1.8

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

577.2

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

393.6

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3044007) Cell count panel - Peritoneal fluid

0.91

0.00

2.3

2.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.0

—

(3035933) Granulocytes/100 leukocytes in Blood

1.02

0.00

2.4

2.1

—

(4038314)

0.00

0.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.89

0.00

1.1

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CONJUHAEMOR and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_CONJUHAEMOR	1.172 [1.04, 1.32]	0.01
Birth year	0.993 [0.98, 1.0]	0.107

During the follow-up period (1.1.1998 — 31.12.2019), 1283 out of 7818 females with H7_CONJUHAEMOR died.

Males

Parameter	HR [95% CI]	p-value
H7_CONJUHAEMOR	1.187 [1.05, 1.35]	0.008
Birth year	0.991 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 1396 out of 6926 males with H7_CONJUHAEMOR died.

Mortality risk

Mortality risk for people of age

years, who have H7_CONJUHAEMOR.

N-year risk	Females	Males
1	0.108%	0.274%
5	0.597%	1.553%
10	1.715%	3.803%
15	3.438%	7.197%
20	5.735%	12.1%

Relationships between endpoints

↥

Index endpoint: H7_CONJUHAEMOR – conjunctival haemorrhage

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

conjunctival haemorrhage

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints